Kiltearn Partners LLP Raises Stock Position in Cigna Group $CI

Kiltearn Partners LLP grew its stake in Cigna Group (NYSE:CI) by 8.8% in the 3rd quarter, Holdings Channel.com reports. The fund owned 97,800 shares of the health services provider’s stock after purchasing an additional 7,900 shares during the quarter. Cigna Group makes up 5.7% of Kiltearn Partners LLP’s holdings, making the stock its 5th largest holding. Kiltearn Partners LLP’s holdings in Cigna Group were worth $28,191,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also modified their holdings of the company. Harbor Capital Advisors Inc. raised its holdings in Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares in the last quarter. Collier Financial bought a new position in Cigna Group in the third quarter valued at approximately $34,000. Traub Capital Management LLC acquired a new position in shares of Cigna Group during the 2nd quarter worth approximately $48,000. Twin Peaks Wealth Advisors LLC acquired a new position in shares of Cigna Group during the 2nd quarter worth approximately $52,000. Finally, CNB Bank raised its stake in shares of Cigna Group by 479.4% during the 3rd quarter. CNB Bank now owns 197 shares of the health services provider’s stock worth $57,000 after purchasing an additional 163 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on CI. Mizuho set a $325.00 target price on shares of Cigna Group in a research note on Friday, January 9th. Piper Sandler cut their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Barclays decreased their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Finally, Truist Financial upped their target price on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $330.42.

Cigna Group Stock Down 3.5%

CI opened at $271.50 on Monday. The stock’s fifty day simple moving average is $280.71 and its 200 day simple moving average is $283.97. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The stock has a market cap of $71.55 billion, a PE ratio of 12.24, a price-to-earnings-growth ratio of 0.94 and a beta of 0.27. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the previous year, the business posted $6.64 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.